Back to Search
MISHA ROSENBACH, MD
MD
Internal Medicine Physician
NPI: 1659421790IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MT184703(PA)MD436574(PA)
CMS Specialties
PrimaryDERMATOLOGY
Education
JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Class of 2004
Research & Publications (20)
Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
PMID 19665821·J Am Acad Dermatol·2010
6-review
Reliability and convergent validity of two outcome instruments for pemphigus.
PMID 19357707·J Invest Dermatol·2009
4-observational
Characteristics, access, utilization, satisfaction, and outcomes of healthy start participants in eight sites.
PMID 19590941·Matern Child Health J·2010
8-other
Intermediate outcomes, strategies, and challenges of eight healthy start projects.
PMID 19011959·Matern Child Health J·2010
8-other
Neutrophilic dermatosis complicating lenalidomide therapy.
PMID 19577327·J Am Acad Dermatol·2009
5-case
Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
PMID 19289781·Arch Dermatol·2009
5-case
Lenalidomide for the treatment of resistant discoid lupus erythematosus.
PMID 19289762·Arch Dermatol·2009
5-case
SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties.
PMID 17092714·Bioorg Med Chem Lett·2007
7-preclinical
Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes.
PMID 16697189·Bioorg Med Chem Lett·2006
7-preclinical
Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
PMID 16682185·Bioorg Med Chem Lett·2006
7-preclinical
2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors.
PMID 16621543·Bioorg Med Chem Lett·2006
7-preclinical
2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists.
PMID 16580205·Bioorg Med Chem Lett·2006
7-preclinical
Frizzled-related protein variants are risk factors for hip osteoarthritis.
PMID 16572458·Arthritis Rheum·2006
8-other
Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
PMID 16190743·J Med Chem·2005
7-preclinical
A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.
PMID 15615513·J Med Chem·2004
7-preclinical
Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.
PMID 15459201·J Biol Chem·2004
7-preclinical
Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors.
PMID 15341940·Bioorg Med Chem Lett·2004
7-preclinical
Synthesis, stereochemical determination and biochemical characterization of the enantiomeric phosphate esters of the novel immunosuppressive agent FTY720.
PMID 15336258·Bioorg Med Chem·2004
7-preclinical
Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists.
PMID 15177461·Bioorg Med Chem Lett·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 CIVIC CENTER BLVD, 1-330S PERELMAN CENTER
PHILADELPHIA, PA 19104 - Phone
- (215) 662-2737
Quick Facts
- NPI
- 1659421790
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile